ArticlePloS one2019
The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma.
S Di Matteo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
28 papers cite it
this papercites it
ArticlePloS one2019
S Di Matteo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.